Liotrix (t4
Generic Name: liotrix (t4
Manufactured by PARKE DAVIS. Dosage form: TABLET. Route: ORAL. Active ingredients: LIOTRIX (T4 (0.06MG); T3) (0.015MG). Application: NDA016680.
Overview
Manufactured by PARKE DAVIS. Dosage form: TABLET. Route: ORAL. Active ingredients: LIOTRIX (T4 (0.06MG); T3) (0.015MG). Application: NDA016680.
Dosage
Available as tablet for oral use.
Related Medications
Epcoritamab-bysp
epcoritamab-bysp
Bispecific CD20-directed CD3 T Cell Engager [EPC]
11 DESCRIPTION Epcoritamab-bysp is a bispecific CD20-directed CD3 T-cell engager; it is a humanized bispecific IgG1 antibody. Epcoritamab-bysp is manufactured in Chinese hamster ovary (CHO) cells using recombinant DNA technology and has an approximate molecular weight of 149 kDa. EPKINLY (epcoritamab-bysp) injection for subcutaneous use is a sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution, free of visible particles.
Ferric Pyrophosphate Citrate
ferric pyrophosphate citrate
Manufactured by ROCKWELL MEDICAL INC. Dosage form: POWDER. Route: INTRAVENOUS. Active ingredients: FERRIC PYROPHOSPHATE CITRATE (272MG IRON/PACKET). Application: NDA208551.
Ceftriaxone Sodium Sterile Bulk
ceftriaxone sodium sterile bulk
Dosage form: POWDER. Active ingredients: CEFTRIAXONE SODIUM (1 kg/kg). Category: BULK INGREDIENT.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.